Related Experiment Video
Updated: Oct 14, 2025

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
miR-152-mediated MKK7 downregulation is attenuated by MYCNOS in ovarian adenocarcinoma
Guifang Zhang1, Dan Zheng1, Xiaoqing Chen2
1Department of Obstetrics and Gynecology, The Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330008, P.R. China.
Abstract:
MYCN opposite strand (MYCNOS) acts as an oncogenic long non-coding RNA in liver cancer. However, its role in other cancer types is unknown. The aim of the present study was to investigate the function of MYCNOS in ovarian adenocarcinoma (OA). MYCNOS expression in OA was determined using reverse transcription-quantitative PCR (RT-qPCR), and its prognostic value for OA was evaluated in a 5-year follow-up study. The predicted interaction between MYCNOS and microRNA (miR)-152 was confirmed using a dual luciferase reporter assay. The association between MYCNOS and miR-152 was also analyzed in overexpression experiments. The effects of MYCNOS and miR-152 on mitogen-activated protein kinase kinase 7 (MKK7) expression were explored using RT-qPCR and western blotting. Cell proliferation was analyzed using a Cell Counting Kit-8 assay. MYCNOS expression was found to be upregulated in OA and predicted poor survival. In addition, MYCNOS was predicted to interact with miR-152, and a dual luciferase assay confirmed this interaction. However, MYCNOS and miR-152 overexpression did not affect their mutual expression levels. MYCNOS overexpression upregulated MKK7, a target of miR-152. Cell proliferation increased following simultaneous MYCNOS and MKK7 overexpression, but was reduced following miR-152 overexpression. Moreover, MYCNOS overexpression attenuated the effects of miR-152 overexpression. In conclusion, MYCNOS may act by sponging miR-152 to upregulate MKK7 expression in OA, thereby promoting cell proliferation.
Insights
MYCN opposite strand (MYCNOS) is upregulated in ovarian adenocarcinoma, promoting cancer cell proliferation by sponging miR-152 and upregulating MKK7. This oncogenic lncRNA indicates poor prognosis in OA patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The oncogenic role of MYCN opposite strand (MYCNOS) long non-coding RNA is established in liver cancer.
- Its function in ovarian adenocarcinoma (OA) remains largely unexplored.
Purpose of the Study:
- To investigate the role and mechanism of MYCNOS in ovarian adenocarcinoma.
- To determine the prognostic value of MYCNOS in OA.
Main Methods:
- MYCNOS expression analyzed via RT-qPCR.
- Prognostic value assessed in a 5-year follow-up.
- MYCNOS-miR-152 interaction confirmed using dual luciferase reporter assay.
- Effects on MKK7 expression and cell proliferation evaluated.
Main Results:
- MYCNOS expression is significantly upregulated in OA tissues.
- High MYCNOS expression correlates with poor patient survival.
- MYCNOS sponges miR-152, leading to MKK7 upregulation and increased cell proliferation.
- MYCNOS overexpression counteracts miR-152's inhibitory effects.
Conclusions:
- MYCNOS functions as an oncogenic lncRNA in ovarian adenocarcinoma.
- MYCNOS promotes OA cell proliferation by inhibiting miR-152 and upregulating MKK7.
- MYCNOS serves as a potential prognostic biomarker for OA.
Related Concept Videos
MicroRNAs
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

